BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35069683)

  • 1. Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma.
    Chen P; Li Y; Li N; Shen L; Li Z
    Front Genet; 2021; 12():781538. PubMed ID: 35069683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma.
    Shen L; Li Y; Li N; Zhao Y; Zhou Q; Shen L; Li Z
    Sci Rep; 2022 Mar; 12(1):4527. PubMed ID: 35296768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients.
    Tanzhu G; Li N; Li Z; Zhou R; Shen L
    Front Oncol; 2022; 12():779168. PubMed ID: 35237509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
    Huang Q; Li J; Mo L; Zhao Y
    World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma.
    Yang Z; Chen Z; Wang Y; Wang Z; Zhang D; Yue X; Zheng Y; Li L; Bian E; Zhao B
    Front Oncol; 2022; 12():717926. PubMed ID: 35433410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the prognosis of glioma by pyroptosis-related signature.
    Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F
    J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
    He J; Zhou W; Zhang M
    Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
    Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
    Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas.
    Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J
    Front Genet; 2023; 14():1087563. PubMed ID: 36861130
    [No Abstract]   [Full Text] [Related]  

  • 13. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas.
    Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L
    Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas.
    Feng X; Chen Y; Liu X; Zhong Z; Liu Y
    J Oncol; 2022; 2022():7043431. PubMed ID: 36281290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.
    Lai G; Li K; Deng J; Liu H; Xie B; Zhong X
    J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer.
    Tu Y; Ding X; Mao Z
    Front Cell Dev Biol; 2022; 10():912008. PubMed ID: 36120583
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes.
    Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H
    World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in Gliomas.
    Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y
    Int J Gen Med; 2022; 15():4753-4769. PubMed ID: 35571289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.